Clinical Trial

Precision Microbiota Interventions for Senoreduction Trial

Name: Precision Microbiota Interventions for Senoreduction Trial — clinical trial record (NCT07462767)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PreMIS

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.

Trial Details

NCT Number	NCT07462767
Lead Sponsor	Louisiana State University Health Sciences Center in New Orleans
Conditions	HIV Infections, Alcohol Drinking, Aging, Immunosenescence
Enrollment	160 participants
Start Date	2026-04-01
Primary Completion	2029-12-01 (estimated)
Study Completion	2029-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-10